3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
3
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
281
Head and Neck Neoplasms
258
Nasopharyngeal Carcinoma
127
Oropharyngeal Neoplasms
57
Carcinoma, Squamous Cell
54
Nasopharyngeal Neoplasms
41
Laryngeal Neoplasms
35
Mouth Neoplasms
30
Hypopharyngeal Neoplasms
29
Carcinoma
24
Salivary Gland Neoplasms
19
Carcinoma, Non-Small-Cell Lung
16
Tongue Neoplasms
15
Neoplasm Metastasis
13
Laryngeal Diseases
13
Recurrence
12
Neoplasms
10
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Mucositis
8
Stomach Neoplasms
7
Pharyngeal Neoplasms
7
Papillomavirus Infections
7
Ovarian Neoplasms
7
Lung Neoplasms
7
Radiation Injuries
6
Pancreatic Neoplasms
6
Neoplasms, Squamous Cell
6
Esophageal Neoplasms
6
Colorectal Neoplasms
6
Thyroid Neoplasms
5
Interventions
selpercatinib
2
pralsetinib
2
repotrectinib
1
pembrolizumab
1
alectinib
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Respiratory Tract Diseases
×
Cisplatin
×
Head & Neck
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts